SUMMARY OF THE STUDY
The authors identified all cases of hyperthyroidism and hypothyroidism diagnosed during 2014-2016 in a group of about 300,000 people living in an area in the north of Denmark. The authors reviewed the medical records of the patients with abnormal thyroid levels to look for the specific causes of hyperthyroidism and hypothyroidism. They compared these results with those from an identical study done during 1997-2000, just before the mandatory iodine supplementation took effect.
The study found that, during 2014-2016, the rate of hyperthyroidism in this population was about 50 in 100,000 individuals. When they compared these results with the prior survey (before iodine supplementation), they found that the rate of hyperthyroidism was 50% lower. The decrease of hyperthyroidism was mostly due to a decrease in the rate of toxic nodular goiters. The chances of hyperthyroidism decreased in all age groups, but it was most significant in middle age and older individuals. The rates of underactive thyroid disease were not affected.
WHAT ARE THE IMPLICATIONS OF THIS STUDY?
The results of this study confirm that programs that mandate iodine supplementation in the form of iodized salt are safe and effective. Further, over the long term, iodine supplementation may also lower the chances of hyperthyroidism, presumably by lowering the stimulus to thyroid growth and nodule formation. Finally, the addition of iodine did not increase the chances of hypothyroidism.
— Susana Ebner MD